UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | K | L | M | N | O | P | R | S | T | V | W | Z
Number of items: 96.

A

AViolet, J; Dearling, JLJ; Green, AJ; Begent, RHJ; Pedley, RB; (2008) Fractionated I-131 anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice. BRIT J CANCER , 99 (4) 632 - 638. 10.1038/sj.bjc.6604511.

Ali, K; Camps, M; Pearce, WP; Ji, H; Rückle, T; Kuehn, N; Pasquali, C; (2008) Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. J Immunol , 180 (4) pp. 2538-2544.

Alliouachene, S; Tuttle, RL; Boumard, S; Lapointe, T; Berissi, S; Germain, S; Jaubert, F; (2008) Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. J Clin Invest , 118 (11) pp. 3629-3638. 10.1172/JCI35237.

Alonzi, R.; (2008) Evaluation of the oxygenation and vascularity of prostate cancer using magnetic resonance imaging. Doctoral thesis, University of London. Green open access
file

Arkenau, HT; Arnold, D; Cassidy, J; Diaz-Rubio, E; Douillard, JY; Hochster, H; Martoni, A; (2008) Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials. J Clin Oncol , 26 (36) pp. 5910-5917. 10.1200/JCO.2008.16.7759.

Arkenau, HT; Graeven, U; Kubicka, S; Grothey, A; Englisch-Fritz, C; Kretzschmar, A; Greil, R; (2008) Oxaliplatin in combination with 5-fluorouracil/leucovorin or capecitabine in elderly patients with metastatic colorectal cancer. Clin Colorectal Cancer , 7 (1) pp. 60-64.

Arkenau, HT; Olmos, D; Ang, JE; Barriuso, J; Karavasilis, V; Ashley, S; de Bono, J; (2008) 90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial? Eur J Cancer , 44 (11) pp. 1536-1540. 10.1016/j.ejca.2008.04.017.

Arkenau, HT; Olmos, D; Ang, JE; de Bono, J; Judson, I; Kaye, S; (2008) Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience. Br J Cancer , 98 (6) pp. 1029-1033. 10.1038/sj.bjc.6604218.

Ayaru, L; Stoeber, K; Webster, GJ; Hatfield, ARW; Wollenschlaeger, A; Okoturo, O; Rashid, M; (2008) Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in bile aspirates. BRIT J CANCER , 98 (9) 1548 - 1554. 10.1038/sj.bjc.6604342. Gold open access

B

Ben-Smith, A; Gorak-Stolinska, P; Floyd, S; Weir, RE; Lalor, MK; Mvula, H; Crampin, AC; (2008) Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus? BMC Infectious Diseases , 8 , Article 139. 10.1186/1471-2334-8-139. Green open access
file

Bhatti, M; Yahioglu, G; Milgrom, LR; Garcia-Maya, M; Chester, KA; Deonarain, MP; (2008) Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments. INT J CANCER , 122 (5) 1155 - 1163. 10.1002/ijc.23206.

Bielack, SS; Marina, N; Ferrari, S; Helman, LJ; Smeland, S; Whelan, JS; Reaman, GH; (2008) Osteosarcoma: The same old drugs or more? J CLIN ONCOL , 26 (18) 3102 - 3103. 10.1200/JCO.2008.17.1108.

Bilanges, B; Torbett, N; Vanhaesebroeck, B; (2008) Killing two kinase families with one stone. Nat Chem Biol , 4 (11) pp. 648-649. 10.1038/nchembio1108-648.

Booth, CM; Calvert, AH; Giaccone, G; Lobbezoo, MW; Eisenhauer, EA; Seymour, LK; Task Force Methodology Dev Innovat, ; (2008) Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT). EUR J CANCER , 44 (1) 25 - 29. 10.1016/j.ejca.2007.07.031.

Booth, CM; Calvert, AH; Giaccone, G; Lobbezoo, MW; Seymour, LK; Eisenhauer, EA; Task Force Methodology Dev Innovat, ; (2008) Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative Cancer Therapies (MDICT). EUR J CANCER , 44 (1) 19 - 24. 10.1016/j.ejca.2007.07.034.

Bridgewater, J; van Laar, R; Floore, A; Van't Veer, L; (2008) Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. BRITISH JOURNAL OF CANCER , 98 (8) pp. 1425-1430. 10.1038/sj.bjc.6604315.

Brown, T; Mackay, H; Turlington, M; Sutterfield, A; Smith, T; Sielaff, A; Westrate, L; (2008) Modifying the N-terminus of polyamides: PyImPyIm has improved sequence specificity over f-ImPyIm. BIOORGAN MED CHEM , 16 (9) 5266 - 5276. 10.1016/j.bmc.2008.03.008.

Buchler, T; Dubash, S; Lee, V; Chilton, D; Cartledge, J; Isaacson, P; Tedder, RS; (2008) Rituximab failure in fulminant multicentric HIV/human herpesvirus 8-associated Castleman's disease with multiorgan failure: report of two cases. AIDS , 22 (13) pp. 1685-1687.

C

Calvert, AH; Plummer, R; (2008) The development of phase I cancer trial methodologies: the use of pharmacokinetic and pharmacodynamic end points sets the scene for phase 0 cancer clinical trials. CLIN CANCER RES , 14 (12) 3664 - 3669. 10.1158/1078-0432.CCR-07-4559.

Cassoni, A; Ali, U; Cave, J; Edwards, SG; Ramsay, A; Miller, RF; Lee, SM; (2008) Remission After Radiotherapy for a Patient With Chemotherapy-Refractory HIV-Associated Primary Effusion Lymphoma. J CLIN ONCOL , 26 (32) 5297 - 5299. 10.1200/JCO.2008.18.3350.

Cassoni, A; Ali, U; Cave, J; Edwards, SG; Ramsay, A; Miller, RF; Siow, ML; (2008) Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma. Journal of Clinical Oncology , 26 (32) pp. 5297-5299. 10.1200/JCO.2008.18.3350.

Chen, YC; Chiang, HY; Yang, MH; Chen, PM; Chang, SY; Teng, SC; Vanhaesebroeck, B; (2008) Activation of phosphoinositide 3-kinase by the NBS1 DNA repair protein through a novel activation motif. J Mol Med (Berl) , 86 (4) pp. 401-412. 10.1007/s00109-008-0302-x.

Chung, YL; Troy, H; Kristeleit, R; Aherne, W; Jackson, LE; Atadja, P; Griffiths, JR; (2008) Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts. Neoplasia , 10 (4) pp. 303-313. Gold open access

Clingen, PH; Wu, JYH; Miller, J; Mistry, N; Chin, F; Wynne, P; Prise, KM; (2008) Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy. BIOCHEM PHARMACOL , 76 (1) 19 - 27. 10.1016/j.bcp.2008.03.025.

Cuenca, F; Greciano, O; Gunaratnam, M; Haider, S; Munnur, D; Nanjunda, R; Wilson, WD; (2008) Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands. Bioorg Med Chem Lett , 18 (5) pp. 1668-1673. 10.1016/j.bmcl.2008.01.050.

D

Drew, Y; Calvert, H; (2008) The Potential of PARP Inhibitors in Genetic Breast and Ovarian Cancers. RECENT ADVANCES IN CLINICAL ONCOLOGY , 1138 136 - 145. 10.1196/annals.1414.020.

Drewe, WC; Nanjunda, R; Gunaratnam, M; Beltran, M; Parkinson, GN; Reszka, AP; Wilson, WD; (2008) Rational Design of Substituted Diarylureas: A Scaffold for Binding to G-Quadruplex Motifs. JOURNAL OF MEDICINAL CHEMISTRY , 51 (24) pp. 7751-7767. 10.1021/jm801245v.

de Bono, JS; Kristeleit, R; Tolcher, A; Fong, P; Pacey, S; Karavasilis, V; Mita, M; (2008) Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors. Clin Cancer Res , 14 (20) pp. 6663-6673. 10.1158/1078-0432.CCR-08-0376.

de Bruin, EC; Medema, JP; (2008) Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev , 34 (8) pp. 737-749. 10.1016/j.ctrv.2008.07.001.

de Bruin, EC; van de Velde, CJ; van Krieken, JH; Marijnen, CA; Medema, JP; (2008) Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients. Clin Cancer Res , 14 (4) pp. 1073-1079. 10.1158/1078-0432.CCR-07-1597.

E

Eardley, KS; Kubal, C; Zehnder, D; Quinkler, M; Lepenies, J; Savage, CO; Howie, AJ; (2008) The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. KIDNEY INTERNATIONAL , 74 (4) pp. 495-504. 10.1038/ki.2008.183.

F

Fern, L; Davies, S; Eden, T; Feltbower, R; Grant, R; Hawkins, M; Lewis, I; (2008) Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: Report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. BRIT J CANCER , 99 (12) 1967 - 1974. 10.1038/sj.bjc.6604751.

Fidarova, EF; El-Emir, E; Boxer, GM; Qureshi, U; Dearling, JLJ; Robson, MP; Begent, RHJ; (2008) Microdistribution of targeted, fluorescently labeled anti carcinoembryonic antigen antibody in metastatic colorectal cancer: Implications for radioimmunotherapy. CLIN CANCER RES , 14 (9) 2639 - 2646. 10.1158/1078-0432.CCR-07-2031.

Folarin, A.A.; (2008) Analysis of tumour angio-architecture and blood flow using microcomputed tomography and lattice Boltzmann simulations. Doctoral thesis, University of London. Green open access
file

Fox, J; Black, E; Chronakis, I; Dunlop, R; Patkar, V; South, M; Thomson, R; (2008) From guidelines to careflows: modelling and supporting complex clinical processes. Stud Health Technol Inform , 139 pp. 44-62.

G

Gaya, A; Daley, F; Taylor, NJ; Tozer, G; Qureshi, U; Padhani, A; Pedley, RB; (2008) Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. BRIT J CANCER , 99 (2) 321 - 326. 10.1038/sj.bjc.6604426.

Graham, JS; Plummer, R; McCoy, C; Kowal, K; Wiesinger, H; Detjen, K; Calvert, H; (2008) Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery). EUR J CANCER , 44 (15) 2162 - 2168. 10.1016/j.ejca.2008.06.006.

Graupera, M; Guillermet-Guibert, J; Foukas, LC; Phng, LK; Cain, RJ; Salpekar, A; Pearce, W; (2008) Angiogenesis selectively requires the p110 alpha isoform of PI3K to control endothelial cell migration. NATURE , 453 (7195) 662 - U9. 10.1038/nature06892.

Green, AJ; Francis, RJ; Baig, S; Begent, RHJ; (2008) Semiautomatic volume of interest drawing for F-18-FDG image analysis - method and preliminary results. EUR J NUCL MED MOL I , 35 (2) 393 - 406. 10.1007/s00259-007-0602-3.

Guillermet-Guibert, J; Bjorklof, K; Salpekar, A; Gonella, C; Ramadani, F; Bilancio, A; Meek, S; (2008) The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci U S A , 105 (24) pp. 8292-8297. 10.1073/pnas.0707761105.

Guo, H; Samarakoon, A; Vanhaesebroeck, B; Malarkannan, S; (2008) The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. J Exp Med , 205 (10) pp. 2419-2435. 10.1084/jem.20072327.

H

Harrison, M; Swanton, C; (2008) Epothilones and new analogues of the microtubule modulators in taxane-resistant disease. Expert Opin Investig Drugs , 17 (4) pp. 523-546. 10.1517/13543784.17.4.523.

Hazrati, A; Ramis-Castelitort, M; Sarkar, S; Barber, LJ; Schofield, CJ; Hartley, JA; McHugh, PJ; (2008) Human SNM1A suppresses the DNA repair defects of yeast pso2 mutants. DNA REPAIR , 7 (2) 230 - 238. 10.1016/j.dnarep.2007.09.013.

Hiwarkar, P; Arkenau, HT; Treleaven, J; Morgan, G; Potter, M; Ethell, M; (2008) The feasibility of using topotecan, vinorelbine, thiotepa and gemcitabine (TVTG) in adult patients with relapsed/refractory acute lymphoblastic leukaemia/lymphoma. LEUKEMIA , 22 (8) 1627 - 1629. 10.1038/leu.2008.31.

Howie, AJ; (2008) Handbook of renal biopsy pathology. (2nd ed. ed.). Springer: New York, USA.

Howie, AJ; Agarwal, A; Sebire, NJ; Trompeter, RS; (2008) Glomerular tip changes in childhood minimal change nephropathy. PEDIATR NEPHROL , 23 (8) 1281 - 1286. 10.1007/s00467-008-0823-0.

Howie, AJ; Brewer, DB; Howell, D; Jones, AP; (2008) Physical basis of colors seen in Congo red-stained amyloid in polarized light. LAB INVEST , 88 (3) 232 - 242. 10.1038/labinvest.3700714.

K

Karavasilis, V; Digue, L; Arkenau, T; Eaton, D; Stapleton, S; de Bono, J; Judson, I; (2008) Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital. Eur J Cancer , 44 (7) pp. 978-982. 10.1016/j.ejca.2008.02.040.

Kogelberg, H; Tolner, B; Thomas, GJ; Di Cara, D; Minogue, S; Ramesh, B; Sodha, S; (2008) Engineering a single-chain Fv antibody to alpha v beta 6 integrin using the specificity-determining loop of a foot-and-mouth disease virus. JOURNAL OF MOLECULAR BIOLOGY , 382 (2) pp. 385-401. 10.1016/j.jmb.2008.07.013.

Kotecha, M; Kluza, J; Wells, G; O'Hare, CC; Forni, C; Mantovani, R; Howard, PW; (2008) Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78. MOL CANCER THER , 7 (5) 1319 - 1328. 10.1158/1535-7163.MCT-07-0475.

Krishnamoorthy, N; Oriss, TB; Paglia, M; Fei, M; Yarlagadda, M; Vanhaesebroeck, B; Ray, A; (2008) Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med , 14 (5) pp. 565-573. 10.1038/nm1766.

L

Lee, AJX; East, P; Pepper, S; Nicke, B; Szallasi, Z; Eklund, AC; Downward, J; (2008) Concordance of exon array and real-time PCR assessment of gene expression following cancer cell cytotoxic drug exposure. CELL CYCLE , 7 (24) pp. 3947-3948. 10.4161/cc.7.24.7217.

Lee, SM; Buchler, T; Bomanji, J; Ramsay, A; Edwards, SG; (2008) Thymic (18)F-fluorodeoxyglucose uptake on positron emission tomography scanning after doxorubicin, bleomycin, vincristin and dacarbazine chemotherapy and highly-active antiretroviral therapy in HIV-associated Hodgkin's disease in an adult. AIDS , 22 (1) pp. 159-160.

Lee, SM; Buchler, T; Joseph, T; Lai, C; (2008) Bilateral eardrum perforation after long-term treatment with erlotinib. JOURNAL OF CLINICAL ONCOLOGY , 26 (15) pp. 2582-2584. 10.1200/JCO.2007.15.3387.

Lee, SM; James, L; Buchler, T; Snee, M; Ellis, P; Hackshaw, A; (2008) Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer. LUNG CANCER , 59 (3) pp. 364-368. 10.1016/j.lungcan.2007.08.032.

M

Mackay, H; Brown, T; Sexton, JS; Kotecha, M; Nguyen, B; Wilson, WD; Kluza, J; (2008) Targeting the inverted CCAAT Box-2 of the topoisomerase II alpha gene: DNA sequence selective recognition by a polyamide-intercalator as a staggered dimer. BIOORGAN MED CHEM , 16 (4) 2093 - 2102. 10.1016/j.bmc.2007.10.059.

Mackay, H; Brown, T; Uthe, PB; Westrate, L; Sielaff, A; Jones, J; Lajiness, JP; (2008) Sequence specific and high affinity recognition of 5 '-ACGCGT-3 ' by rationally designed pyrrole-imidazole H-pin polyamides: Thermodynamic and structural studies. BIOORGAN MED CHEM , 16 (20) 9145 - 9153. 10.1016/j.bmc.2008.09.034.

Moorhouse, AD; Haider, S; Gunaratnam, M; Munnur, D; Neidle, S; Moses, JE; (2008) Targeting telomerase and telomeres: a click chemistry approach towards highly selective G-quadruplex ligands. Mol Biosyst , 4 (6) pp. 629-642. 10.1039/b801822g.

Muller, CI; Schulmann, K; Reinacher-Schick, A; Andre, N; Arnold, D; Tannapfel, A; Arkenau, H; (2008) Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group. INT J COLORECTAL DIS , 23 (11) 1033 - 1039. 10.1007/s00384-008-0504-2.

N

Ng, Q.S.; (2008) Therapeutic targeting and clinical assessment of the tumour vasculature. Doctoral thesis, University of London. Green open access
file

O

Olmos, D; Swanton, C; de Bono, J; (2008) Targeting polo-like kinase: learning too little too late? J Clin Oncol , 26 (34) pp. 5497-5499. 10.1200/JCO.2008.18.6585.

P

Papakonstanti, EA; Zwaenepoel, O; Bilancio, A; Burns, E; Nock, GE; Houseman, B; Shokat, K; (2008) Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages. J Cell Sci , 121 (Pt 24) pp. 4124-4133. 10.1242/jcs.032763.

Patkar, V; Fox, J; (2008) Clinical guidelines and care pathways: a case study applying PROforma decision support technology to the breast cancer care pathway. Stud Health Technol Inform , 139 pp. 233-242.

Patterson, DM; Murugaesu, N; Holden, L; Seckl, MJ; Rustin, GJ; (2008) A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer , 18 (1) pp. 43-50. 10.1111/j.1525-1438.2007.00969.x.

Paulussen, M; Craft, AW; Lewis, I; Hackshaw, A; Douglas, C; Dunst, J; Schuck, A; (2008) Results of the EICESS-92 study: Two randomized trials of Ewing's sarcoma treatment - Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J CLIN ONCOL , 26 (27) 4385 - 4393. 10.1200/JCO.2008.16.5720.

Philippar, U; Roussos, ET; Oser, M; Yamaguchi, H; Kim, HD; Giampieri, S; Wang, YR; (2008) A Mena Invasion Isoform Potentiates EGF-Induced Carcinoma Cell Invasion and Metastasis. DEV CELL , 15 (6) 813 - 828. 10.1016/j.devcel.2008.09.003.

Pillai, RG; Forster, M; Perumal, M; Mitchell, F; Leyton, J; Aibgirhio, FI; Golovko, O; (2008) Imaging pharmacodynamics of the alpha-folate receptor-targeted thymidylate synthase inhibitor BGC 945. Cancer Res , 68 (10) pp. 3827-3834. 10.1158/0008-5472.CAN-08-0135.

Pipinikas, CP; Carter, ND; Corbishley, CM; Fenske, CD; (2008) HIF-1 alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer. BIOMARKERS , 13 (7-8) pp. 680-691. 10.1080/13547500802591992.

Plummer, R; Jones, C; Middleton, M; Wilson, R; Evans, J; Olsen, A; Curtin, N; (2008) Phase I Study of the Poly (ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors. CLIN CANCER RES , 14 (23) 7917 - 7923. 10.1158/1078-0432.CCR-08-1223.

Popat, R; Maharaj, L; Oakervee, H; Cavenagh, J; Middleton, B; Rioja, A; Marson, C; (2008) THE NOVEL HDAC INHIBITOR UCL67022 HAS POTENT ACTIVITY IN MULTIPLE MYELOMA CELLS AND REMAINS EFFECTIVE IN A BONE MARROW MICRO-ENVIRONMENT MODEL. In: (Proceedings) 13th Congress of the European-Hematology-Association. (pp. p. 115). FERRATA STORTI FOUNDATION Gold open access

Post, FA; Campbell, LJ; Hamzah, L; Collins, L; Jones, R; Siwani, R; Johnson, L; (2008) Predictors of renal outcome in HIV-associated nephropathy. CLINICAL INFECTIOUS DISEASES , 46 (8) pp. 1282-1289. 10.1086/529385.

R

Ray-Coquard, I; Le Cesne, A; Whelan, JS; Schoffski, P; Bui, BN; Verweij, J; Marreaud, S; (2008) A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens. ONCOLOGIST , 13 (4) 467 - 473. 10.1634/theoncologist.2008-0065.

Reed, J; Gunaratnam, M; Beltran, M; Reszka, AP; Vilar, R; Neidle, S; (2008) TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules. Anal Biochem , 380 (1) pp. 99-105. 10.1016/j.ab.2008.05.013.

S

Sarkaria, JN; Kitange, GJ; James, CD; Plummer, R; Calvert, H; Weller, M; Wick, W; (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. CLIN CANCER RES , 14 (10) 2900 - 2908. 10.1158/1078-0432.CCR-07-1719.

Seddon, BM; Whelan, JS; (2008) Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma. Paediatr Drugs , 10 (2) pp. 93-105.

See, TC; Thompson, BC; Howie, AJ; Karamshi, M; Papadopoulou, AM; Davies, N; Tibballs, J; (2008) Transjugular renal biopsy: Our experience and technical considerations. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , 31 (5) pp. 906-918. 10.1007/s00270-008-9308-6.

Shah, T; Kulakiene, I; Quigley, AM; Warbey, VS; Srirajaskanthan, R; Tournpanakis, C; Hochhauser, D; (2008) The role of Tc-99m-depreotide in the management of neuroendocrine tumours. NUCLEAR MEDICINE COMMUNICATIONS , 29 (5) 436 - 440.

Shah, T; Srirajaskanthan, R; Bhogal, M; Toubanakis, C; Meyer, T; Noonan, A; Witney-Smith, C; (2008) beta-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients. BRIT J CANCER , 99 (1) 72 - 77. 10.1038/sj.bjc.6604428.

Siddika, A; Jamal-Hanjani, M; Coker, JB; Ullah, MZ; (2008) Laparoscopy: a tool for the diagnosis and treatment of omental torsion. Int J Clin Pract , 62 (11) pp. 1807-1808. 10.1111/j.1742-1241.2006.00900.x.

Sirohi, B; Cunningham, D; Powles, R; Murphy, F; Arkenau, T; Norman, A; Oates, J; (2008) Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma. Ann Oncol , 19 (7) pp. 1312-1319. 10.1093/annonc/mdn052.

Speetjens, FM; de Bruin, EC; Morreau, H; Zeestraten, EC; Putter, H; van Krieken, JH; van Buren, MM; (2008) Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother , 57 (5) pp. 601-609. 10.1007/s00262-007-0396-y.

Stebbing, J; Harrison, M; Glynne-Jones, R; Bridgewater, J; Propper, D; (2008) A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study). BRITISH JOURNAL OF CANCER , 98 (4) pp. 716-719. 10.1038/sj.bjc.6604232.

Swanton, C; Downward, J; (2008) Unraveling the complexity of endocrine resistance in breast cancer by functional genomics. Cancer Cell , 13 (2) pp. 83-85. 10.1016/j.ccr.2008.01.021.

Swanton, C; Szallasi, Z; Brenton, JD; Downward, J; (2008) Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer. Breast Cancer Res , 10 (5) 214-. 10.1186/bcr2159.

T

Taylor, RE; Pizer, BL; Short, S; (2008) Promoting collaboration between adult and paediatric clinical trial groups. Clin Oncol (R Coll Radiol) , 20 (9) pp. 714-716. 10.1016/j.clon.2008.06.009.

Thirlwell, C; Nathan, P; (2008) Melanoma - Part 2: management. BRIT MED J , 337 , Article a2488. 10.1136/bmj.a2488.

Tiberghien, AC; Evans, DA; Kiakos, K; Martin, CRH; Hartley, JA; Thurston, DE; Howard, PW; (2008) An asymmetric C8/C8 '-tripyrrole-linked sequence-selective pyrrolo[2,1-c][1,4] benzodiazepine (PBD) dimer DNA interstrand cross-linking agent spanning 11 DNA base pairs. BIOORG MED CHEM LETT , 18 (6) 2073 - 2077. 10.1016/j.bmcl.2008.01.096.

V

Vassileva, V; Allen, CJ; Piquette-Miller, M; (2008) Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer. MOLECULAR CANCER THERAPEUTICS , 7 (3) pp. 630-637. 10.1158/1535-7163.MCT-07-2117.

Vassileva, V; Moriyama, EH; De Souza, R; Grant, J; Allen, CJ; Wilson, BC; Piquette-Miller, M; (2008) Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging. BRITISH JOURNAL OF CANCER , 99 (12) pp. 2037-2043. 10.1038/sj.bjc.6604803.

W

Wang, M-L; Panasyuk, G; Gwalter, J; Nemazanyy, I; Fenton, T; Filonenko, V; Gout, I; (2008) Regulation of ribosomal protein S6 kinases by ubiquitination. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , 369 (2) pp. 382-387. 10.1016/j.bbrc.2008.02.032.

Wells, G; Suggitt, M; Coffils, M; Baig, MAH; Howard, PW; Loadman, PM; Hartley, JA; (2008) Fluorescent 7-diethylaminocoumarin pyrrolobenzodiazepine conjugates: Synthesis, DNA interaction, cytotoxicity and differential cellular localization. BIOORG MED CHEM LETT , 18 (6) 2147 - 2151. 10.1016/j.bmcl.2008.01.083.

Whelan, JS; Fern, LA; (2008) Poor accrual of teenagers and young adults into clinical trials in the UK. Lancet Oncol , 9 (4) pp. 306-307. 10.1016/S1470-2045(08)70080-9.

Wilkinson, SJ; Kucukmetin, A; Cross, P; Darby, S; Gnanapragasam, VJ; Calvert, AH; Robson, CN; (2008) Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer. HUM PATHOL , 39 (8) 1197 - 1204. 10.1016/j.humpath.2007.12.011.

Z

Zehnder, D; Quinkler, M; Eardley, KS; Bland, R; Lepenies, J; Hughes, SV; Raymond, NT; (2008) Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. In: (Proceedings) 37th Annual Meeting of the American-Society-of-Nephrology. (pp. pp. 1343-1353). NATURE PUBLISHING GROUP

Zhang, EZ; Laufer, J; Pedley, RB; Beard, P; (2008) 3D photoacoustic imaging system for in vivo studies of small animal models - art. no. 68560P. In: Oraevsky, AA and Wang, LV, (eds.) PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2008: THE NINTH CONFERENCE ON BIOMEDICAL THERMOACOUSTICS, OPTOACOUSTICS, AND ACOUSTIC-OPTICS. (pp. P8560 - P8560). SPIE-INT SOC OPTICAL ENGINEERING

Zhang, TT; Okkenhaug, K; Nashed, BF; Puri, KD; Knight, ZA; Shokat, KM; Vanhaesebroeck, B; (2008) Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. J Allergy Clin Immunol , 122 (4) 811-819.e2. 10.1016/j.jaci.2008.08.008.

This list was generated on Sun Dec 4 03:35:25 2016 GMT.